Concepedia

Ruyue Xu

RX

14

Publications

360

Citations

12

H-Index

2019

Active since

Affiliations

Anhui University of Science and Technology(Current)

First Affiliated Hospital of Bengbu Medical College

Zhejiang University

Jinan University

Guangzhou Medical University

Ruyue Xu is an author at Anhui University of Science and Technology specializing in cell biology, medicine, and cancer biology.

ORCID

Top concepts

Publications per year

2019–2024

14

Publications

14

PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway.

Yinci Zhang, Chunmei Xie, Amin Li et al. · PubMed · 2019 · 44 citations · Full text

, , +17

Curcumin reverses hepatic epithelial mesenchymal transition induced by trichloroethylene by inhibiting IL-6R/STAT3

Weiya Cao, Yinci Zhang, Amin Li et al. · Toxicology Mechanisms and Methods · 2021 · 40 citations

LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells

Yongfang Ma, Ruyue Xu, Xueke Liu et al. · International Journal of Medical Sciences · 2021 · 36 citations · Full text

c-Met up-regulates the expression of PD-L1 through MAPK/NF-κBp65 pathway

Ruyue Xu, Xinkuang Liu, Amin Li et al. · Journal of Molecular Medicine · 2022 · 34 citations

, , +6

BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.

Amin Li, Rongbo Zhang, Yinci Zhang et al. · PubMed · 2019 · 32 citations · Full text

Rows per page

1–5 of 14